Sort
48,018 grants matching “immunotherapy”
Inhibitory Pathways Underlying Viral Persistence In Vivo
$411,840Elina I Zuniga · University Of California, San Diego · R01 · FY2019 · AI
Clinical Fellowship Training Program
$411,774Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2012 · CA
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
$411,770James K Chen · Stanford University · R01 · FY2021 · CA
Regulation of host immunity to impact virus persistence
$411,749Bumsuk Hahm · University Of Missouri-Columbia · R01 · FY2021 · AI
MusIC: A multi-scale technology for integrating dynamic cellular function and molecular profiles
$411,747Navin Varadarajan · University Of Houston · R01 · FY2023 · GM
B cell/T Follicular Helper cell interactions in progression of Leishmaniasis
$411,744Christine A Petersen · University Of Iowa · R56 · FY2018 · AI
FCRL1 in B cell differentiation
$411,695Timothy James Wilson · Miami University Oxford · R15 · FY2023 · AI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES
$411,642Terrence L Geiger · St. Jude Children'S Research Hospital · R01 · FY2011 · AI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES
$411,642Terrence L Geiger · St. Jude Children'S Research Hospital · R01 · FY2012 · AI
Radiotherapy as Immunotherapy of Tumors
$411,640Samuel Strober · Stanford University · R01 · FY2013 · CA
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
$411,639Maurizio Pellecchia · University Of California Riverside · R01 · FY2024 · CA
NOVEL VACCINE TARGETS FOR EARLY STAGE BREAST CANCER
$411,632Benaroya Research Inst At Virginia Mason · R01 · FY2001 · CA
MULTI-EPITOPE MELANOMA VACCINES FOR CD4 AND CD8 T-CELLS
$411,601University Of Virginia Charlottesville · R01 · FY2005 · CA
WEE1 inhibition and tumor immunity
$411,600Bin Zhang · Northwestern University At Chicago · R01 · FY2022 · CA
Investigation of the Cellular and Molecular Mechanisms of Thrombocyte Integrin Signaling
$411,600Zhao Wang · Baylor College Of Medicine · R01 · FY2022 · HL
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$411,598Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2021 · CA
Tumor Immunology Institutional Training Grant
$411,595Steven M. Dubinett · University Of California Los Angeles · T32 · FY2010 · CA
Vaccine and radiation for the therapy of human cancers
$411,584James Hodge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Novel Strategies for Precision T-cell Therapies
$411,577Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$411,554Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
The role of IL-10 in stabilizing natural regulatory T cells
$411,539Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2010 · AI
MusIC: A multi-scale technology for integrating dynamic cellular function and molecular profiles
$411,529Navin Varadarajan · University Of Houston · R01 · FY2024 · GM
ANTIBODY-TARGETED IMMUNOTHERAPY OF CANCER
$411,489Fox Chase Cancer Center · R01 · FY2001 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$411,464Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Project 1: Targeting Tumor Phospholipase PLA2G10 for Cancer Immunotherapy
$411,417Kurt A Schalper · Yale University · P50 · FY2025 · CA